This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Fitting and adjustment of external prosthetic device
Z21_FIT_ADJ_EXTER_PROSTHET_DEVICE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
97 |
4. Check minimum number of eventsNone |
97 |
5. Include endpointsNone |
97 |
6. Filter based on genotype QC (FinnGen only) |
97 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z4|Z5[0-4]
Similar endpoints
↥List of similar endpoints to
Fitting and adjustment of external prosthetic device
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 97 | 61 | 36 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 66.53 | 65.95 | 67.51 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 92
- Matched controls
- 921
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z44.1
ICD-10 Finland
Fitting and adjustment of artificial leg (complete)(partial)
+∞
48.2
42
*
Z44.3
ICD-10 Finland
Fitting and adjustment of external breast prosthesis
+∞
34.6
31
*
NGQ20
NOMESCO Finland
Amputation of lower leg
153.2
30.9
31
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
11.2
18.0
37
52
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
15.7
17.4
29
26
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
205.8
17.1
17
*
S97
ICPC
Chronic ulcer skin
19.7
16.6
25
17
N02AA05
ATC
oxycodone; systemic
9.9
16.4
36
56
XF600
NOMESCO Finland
Bloodpressure measurement
13.9
15.9
28
28
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
16.0
15.8
26
22
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
21.4
15.8
23
14
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
39.3
15.5
19
6
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
15.9
15.2
25
21
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
9.2
14.4
32
50
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
6.6
14.1
43
107
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
47.7
13.7
16
*
N03AX16
ATC
pregabalin; oral
6.2
13.5
44
118
A46
ICD-10 Finland
Erysipelas
7.2
13.3
36
75
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
31.8
12.5
16
6
NFQ20
NOMESCO Finland
Amputation of femur
35.3
12.1
15
5
NHQ40
NOMESCO Finland
Amputation of toe
20.5
11.7
17
10
ZZA00
NOMESCO Finland
Split skin graft
20.5
11.7
17
10
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
29.4
11.6
15
6
TPH07
NOMESCO Finland
Cathetrisation of artery
8.0
11.4
27
45
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
68.1
10.9
12
*
HAC20
NOMESCO Finland
Total mastectomy
12.3
10.6
19
19
Z89.5
ICD-10 Finland
Acquired absence of leg at or below knee
+∞
10.6
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
8.6
10.5
23
34
115
Kela drug reimbursment
Breast cancer
7.6
10.3
25
43
SPAT1229
SPAT
Assessment of need for aid
7.9
10.3
24
39
WX213
NOMESCO Finland
Lower leg blockade
29.9
10.1
13
5
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
29.9
10.1
13
5
SPAT1256
SPAT
Intramuscular and subcutaneous injection
4.3
10.0
58
262
SPAT1262
SPAT
Handing over of treatment supplies
5.0
10.0
37
109
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.7
9.7
23
38
TPH04
NOMESCO Finland
Cathetrisation of vein
4.9
9.7
36
106
C03CA01
ATC
furosemide; systemic
4.4
9.7
46
171
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
24.9
9.7
13
6
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
+∞
9.5
9
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
4.3
9.4
45
166
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.5
9.4
30
74
J01FF01
ATC
clindamycin; systemic
4.2
9.1
44
163
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.3
9.1
25
51
WX306
NOMESCO Finland
Lumbar epidural anesthesy
16.2
9.0
14
10
ZXD05
NOMESCO Finland
Urgent procedure
4.1
8.9
44
168
SPAT1211
SPAT
Application of soft bandage
7.5
8.8
21
35
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
30.8
8.7
11
*
A10AE04
ATC
insulin glargine; parenteral
6.9
8.7
22
40
N03AX12
ATC
gabapentin; oral
5.7
8.7
26
59
SPAT1263
SPAT
Sampling
3.8
8.5
52
234
Z49.1
ICD-10 Finland
Extracorporeal dialysis
+∞
8.5
8
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
8.5
8
*
Z49.2
ICD-10 Finland
Other dialysis
+∞
8.5
8
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
36.9
8.3
10
*
SPAT1260
SPAT
Consultation of another employee
4.7
8.2
30
85
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.8
8.1
46
192
B01AB10
ATC
tinzaparin; parenteral
8.0
8.1
18
27
ZXE20
NOMESCO Finland
More than three and less than five hours
5.3
8.1
26
64
SPAT1249
SPAT
Treatment-related counselling outside office
3.6
8.0
52
242
SPAT1149
SPAT
Suture or treatment of traumatic wound
5.0
7.9
27
71
H3603, E103
ICD-10 Finland
NA
49.3
7.9
9
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
6.0
7.8
22
46
XX3DW
NOMESCO Finland
Time consuming IT work
5.8
7.7
22
47
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.7
7.7
15
18
L89
ICD-10 Finland
Decubitus ulcer and pressure area
15.1
7.6
12
9
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
7.2
7.6
18
30
L04AA06
ATC
mycophenolic acid; systemic
86.8
7.5
8
*
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
86.8
7.5
8
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.5
7.4
46
205
N18.8
ICD-10 Finland
Other chronic renal failure
13.6
7.3
12
10
TPX10
NOMESCO Finland
Implantation of vascular injection port
22.1
7.3
10
5
J01DB01
ATC
cefalexin; oral
5.5
7.2
84
603
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.5
7.1
42
176
H02AB02
ATC
dexamethasone; systemic
6.2
7.1
19
37
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.6
7.1
26
73
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.3
7.1
28
85
SPAT1312
SPAT
General health counselling
3.5
7.0
40
165
WX402
NOMESCO Finland
General anaesthesia
4.2
7.0
28
86
PE1AT
NOMESCO Finland
Femoral artery PTA
18.5
6.9
10
6
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
43.4
6.9
8
*
A04AA02
ATC
granisetron; systemic, transdermal
7.9
6.9
15
22
SPAT1215
SPAT
Assessment of need for medical rehabilitation
9.9
6.8
13
15
X76
ICPC
Malignant neoplasm breast female
24.6
6.8
9
*
B01AB05
ATC
enoxaparin; parenteral
3.4
6.8
43
190
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
3.4
6.8
39
162
WW200
SPAT
NA
4.8
6.7
23
60
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
8.5
6.7
14
19
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
6.9
6.7
16
27
J01MA02
ATC
ciprofloxacin; systemic
3.2
6.6
50
249
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
15.8
6.6
10
7
127
Kela drug reimbursment
Transplant complication
74.8
6.5
7
*
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
74.8
6.5
7
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
74.8
6.5
7
*
WX320
NOMESCO Finland
Spinalanesthesy
3.7
6.5
33
121
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
7.2
6.5
15
24
ZXE00
NOMESCO Finland
One hour or less
3.1
6.5
48
237
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
19.7
6.4
9
5
D64.9
ICD-10 Finland
Anaemia, unspecified
4.8
6.3
21
53
R50.9
ICD-10 Finland
Fever, unspecified
4.8
6.3
21
53
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
28.9
6.3
8
*
Z44.8
ICD-10 Finland
Fitting and adjustment of other external prosthetic devices
+∞
6.3
6
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
6.3
6
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
+∞
6.3
6
*
Z44.2
ICD-10 Finland
Fitting and adjustment of artificial eye
+∞
6.3
6
*
N02AX02
ATC
tramadol; systemic, rectal
3.1
6.3
52
273
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
16.4
6.0
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
18
19.37
29.95
4.2
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
40
73
8.62
23.32
15.4
3.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
17
11
18.53
19.84
5.4
2.5
u/ml
22.6
79.5
0.43
17
11
(3007853) Bacteria identified in Skin by Aerobe culture
41
93
6.90
19.04
4.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
43
104
6.63
18.66
4.6
1.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
16
13.59
17.62
8.9
1.8
%
14.3
16.5
—
12
9
(3029937) Albumin [Presence] in Urine by Test strip
62
221
6.00
17.21
7.1
4.0
estimate
0.0
0.0
0.00
26
73
(3041096) Erythrocytes [Presence] in Urine by Automated
62
223
5.93
16.97
7.4
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
19
11.40
15.72
1.3
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
52
7.16
15.54
2.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
10
16.19
15.36
4.7
4.4
e9/l
5.3
4.5
—
14
10
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
10
16.19
15.36
4.9
6.0
%
62.3
62.2
—
14
10
(3013290) Carbon dioxide [Partial pressure] in Blood
16
15
12.58
15.05
18.9
1.5
kpa
4.7
4.9
0.40
16
15
(3012501) Base excess in Blood by calculation
16
15
12.58
15.05
18.8
1.5
mmol/l
3.0
2.8
—
10
7
(3027315) Oxygen [Partial pressure] in Blood
16
15
12.58
15.05
18.9
1.5
kpa
8.6
8.3
0.19
16
15
(3023368) Bacteria identified in Blood by Culture
56
202
5.19
14.80
17.8
3.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
28
55
6.75
14.67
5.0
2.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
61
245
5.01
13.85
15.8
3.3
ph
7.4
7.4
0.66
24
47
(3021901) Oxygen saturation in Capillary blood
13
10
14.86
13.64
7.2
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
11
13.49
12.90
9.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
16
10.91
12.89
19.0
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
27
58
6.07
12.81
4.1
3.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
14
11.52
12.53
2.8
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
69
322
4.96
12.49
13.0
3.7
g/l
30.8
35.8
7.73
63
301
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
67
308
4.80
12.31
7.4
3.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
12
12.36
12.22
2.5
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
21
37
6.97
12.07
16.5
6.0
mmol/l
22.7
25.3
1.72
21
37
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
43
6.32
11.41
9.1
6.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
70
345
4.70
11.41
17.0
5.1
mmol/l
1.2
1.2
0.22
64
309
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
16
10.06
11.41
2.8
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
69
339
4.59
11.23
7.8
4.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
55
230
4.21
11.23
12.5
5.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
29
76
5.02
10.91
10.1
3.6
—
—
—
0
0
(3026782) Osmolality of Urine
43
154
4.22
10.83
6.2
2.5
mosm/kgh2o
437.9
545.0
3.26
37
135
(3015377) Calcium [Moles/volume] in Serum or Plasma
56
243
4.09
10.72
6.9
2.7
mmol/l
2.3
2.4
1.25
50
217
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
72
375
4.57
10.57
21.8
5.6
mmol/l
1.2
1.2
0.05
54
316
(3025941) Bacteria identified in Stool by Culture
20
39
6.20
10.35
1.4
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
10
12.28
10.35
2.4
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
63
305
4.04
10.12
31.8
8.1
inr
1.4
1.3
0.60
35
91
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
33
103
4.34
9.89
8.2
1.8
%
18.2
20.4
0.51
26
88
(3035350) Ketones [Presence] in Urine by Test strip
72
388
4.32
9.76
7.4
3.8
estimate
0.0
0.0
0.00
28
79
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
11
11.15
9.72
2.4
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
50
212
3.80
9.68
6.3
2.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
53
237
3.73
9.40
5.8
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
72
395
4.19
9.34
7.4
3.8
estimate
0.0
0.0
0.00
25
72
(3021601) Nitrite [Presence] in Urine by Test strip
71
388
4.10
9.22
8.6
5.1
estimate
0.0
0.0
0.00
28
78
(3019309) Folate [Moles/volume] in Red Blood Cells
40
150
3.84
9.21
2.8
1.7
nmol/l
1757.4
1226.5
1.26
30
115
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
18
36
5.91
9.02
5.8
4.1
mmol/l
1.6
2.3
0.60
13
28
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
22
7.27
8.79
6.6
1.9
g/l
124.8
132.1
0.53
14
14
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
10
11.03
8.79
2.8
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
13
9.42
8.64
3.0
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
83
526
5.00
8.28
8.5
4.2
—
—
—
0
0
(3009343) pH of Capillary blood
18
39
5.44
8.27
5.8
3.9
ph
7.4
7.4
—
10
8
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
11
10.02
8.23
2.5
2.0
pg
29.4
32.6
—
10
11
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
5
24.52
8.22
3.0
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
17
7.91
8.19
3.7
2.1
u/ml
0.3
0.2
—
7
9
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
59
304
3.40
8.00
8.1
3.7
ng/l
43.8
35.8
0.21
54
208
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
40
168
3.35
7.51
2.1
1.8
pmol/l
559.8
458.7
0.89
34
144
(40768446) Kidney Pathology biopsy report
7
0
+∞
7.38
2.0
0.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
0
+∞
7.38
5.3
0.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
16
7.63
7.31
2.1
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
39
167
3.23
7.02
5.1
4.1
kg/l
1.0
1.0
0.72
25
22
(3044640) Blood type and Crossmatch panel - Blood
46
220
3.07
6.81
3.7
2.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
9
13.58
6.77
3.0
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
25
83
3.71
6.66
3.4
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
22
6.08
6.47
2.8
2.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
21
63
3.98
6.44
6.7
5.4
%
0.5
0.6
—
10
15
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
25
86
3.57
6.30
3.4
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
30
117
3.26
6.21
3.7
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
38
177
2.89
5.73
2.0
1.5
nmol/l
18.6
22.3
1.02
33
147
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
50
271
2.74
5.62
7.2
3.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
87
3.34
5.54
2.7
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
5
17.24
5.51
2.6
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
72
3.45
5.27
6.8
5.2
%
0.7
0.8
0.04
13
23
(3044889) 12 lead EKG panel
80
565
3.37
5.26
8.3
3.8
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
0
+∞
5.25
5.2
0.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
25
96
3.16
5.24
2.9
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
31
135
2.91
5.22
6.6
3.2
ng/l
518.3
146.1
0.61
21
106
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
73
3.40
5.15
2.7
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
45
241
2.62
5.06
5.2
3.2
mg/l
167.5
564.8
0.53
32
157
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
52
3.75
5.02
3.1
2.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
10
9.77
4.90
1.6
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
19
64
3.45
4.88
7.3
5.5
%
0.0
0.0
—
10
16
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
7
12.30
4.88
3.4
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
7
12.30
4.88
3.4
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
46
258
2.49
4.60
7.8
4.0
mg/mmol
37.0
7.1
0.78
30
163
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
51
301
2.46
4.55
2.0
1.8
pmol/l
100.0
99.1
0.04
29
149
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
9
12
8.13
4.46
2.7
2.1
g/l
3.6
3.5
—
9
12
(40760892) CBC W Ordered Manual Differential panel - Blood
35
178
2.51
4.26
14.4
6.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
85
654
3.42
4.19
67.9
15.5
%
14.6
13.7
4.80
85
642
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
7
10.65
4.08
1.4
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
18
66
3.12
4.02
7.8
5.5
%
0.0
0.2
0.98
11
19
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
29
4.15
3.92
2.2
2.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
58
380
2.31
3.89
13.7
6.0
e9/l
0.2
0.2
0.14
58
347
(40768804) Tissue Pathology biopsy report
50
310
2.26
3.80
3.4
2.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
17
63
3.06
3.72
5.6
6.0
mmol/l
1.6
1.3
0.24
17
63
(3000494) Fungus identified in Specimen by Culture
23
101
2.67
3.72
2.5
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
24
110
2.57
3.56
1.6
1.3
—
—
—
0
0
(44806118)
6
6
10.54
3.54
2.3
2.2
—
—
—
0
0
(44790048)
6
6
10.54
3.54
2.3
2.2
—
—
—
0
0
(44790049)
6
6
10.54
3.54
2.3
2.2
—
—
—
0
0
(44790047)
6
6
10.54
3.54
2.3
2.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
10
7.44
3.42
1.1
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
33
183
2.22
3.19
1.8
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
14
51
3.04
3.14
3.5
3.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
8
7.90
3.10
1.2
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
21
4.61
3.08
1.6
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
55
377
2.06
3.02
12.4
6.0
e9/l
1.5
1.8
2.36
55
343
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
13
5.71
2.92
1.6
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
20
92
2.48
2.92
1.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
85
701
2.72
2.79
45.6
13.2
%
35.4
40.1
5.39
38
495
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
6
8.69
2.78
1.2
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
10
6.31
2.74
4.5
4.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
14
56
2.75
2.67
4.1
2.0
ng/l
319.0
207.2
0.47
14
51
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
15
4.94
2.65
1.6
1.5
—
—
—
0
0
(3015736) pH of Urine
46
307
1.95
2.62
4.4
3.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
45
2.90
2.56
1.8
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
16
4.63
2.52
4.6
3.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
58
2.65
2.50
4.5
3.3
ml/min/173m2
20.8
63.3
—
6
24
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
88
764
2.63
2.46
62.1
12.8
mg/l
28.1
23.6
0.94
83
594
(4035726)
15
66
2.51
2.39
2.1
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
9
5.78
2.24
3.2
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
43
2.76
2.18
2.5
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
26
152
1.97
2.11
2.1
1.3
g/l
3.1
2.3
0.83
17
97
(3023419) Bacteria identified in Sputum by Culture
5
10
5.20
2.09
3.0
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
15
4.19
2.07
1.0
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
58
440
1.79
2.04
2.8
2.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
16
3.92
1.96
1.3
2.0
—
—
—
0
0
(3020891) Body temperature
9
34
2.81
1.92
1.6
5.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
22
3.35
1.92
1.1
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
12
54
2.39
1.82
15.6
6.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
27
169
1.83
1.77
1.6
1.3
u/ml
1.0
0.9
—
6
46
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
131
1.88
1.68
2.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
15
3.45
1.54
4.0
2.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
60
482
1.64
1.53
4.2
2.8
u/l
57.2
49.5
0.21
54
450
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
82
728
1.82
1.30
59.2
12.3
ml/min/173m2
69.5
79.2
2.07
70
577
(40768443) Skin Pathology biopsy report
8
37
2.26
1.25
1.5
1.2
—
—
—
0
0
(3013512) EKG study
31
221
1.59
1.24
6.6
4.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
88
805
2.00
1.22
66.2
11.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
38
2.20
1.21
1.8
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
14
82
1.83
1.12
2.1
3.1
umol/l
6.3
8.8
—
9
74
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
69
597
1.54
1.10
4.9
3.7
pmol/l
14.8
14.9
0.12
64
537
(3020961) Endomysium IgA Ab [Titer] in Serum
9
45
2.10
1.08
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
22
2.34
1.04
1.8
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
22
2.34
1.04
1.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
36
2.02
0.99
1.0
1.3
—
—
—
0
0
(4034850)
0
30
0.00
0.99
0.0
8.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
29
2.14
0.91
1.7
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
20
140
1.54
0.86
1.1
1.3
iu/ml
66.2
45.3
—
10
53
(1002224) Polysomnography panel
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
(4094501)
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
87
812
1.69
0.79
62.6
15.3
umol/l
97.2
75.3
1.72
87
812
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
23
2.24
0.77
1.8
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
81
746
1.52
0.76
9.5
5.9
mmol/mol
44.1
40.6
1.29
73
686
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
24
2.14
0.75
1.6
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
78
1.61
0.69
1.3
1.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
21
0.00
0.61
0.0
1.2
—
88.8
—
0
21
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
12
81
1.55
0.60
3.6
3.9
ug/l
7.6
4.3
—
6
67
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
79
736
1.40
0.57
5.1
4.0
mmol/l
1.5
1.3
0.98
72
666
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
81
758
1.42
0.57
6.2
4.7
mmol/l
6.3
6.0
0.61
71
683
(3021447) Carbon dioxide [Partial pressure] in Venous blood
9
60
1.55
0.56
14.2
3.0
kpa
6.3
5.6
—
9
60
(3012544) pH of Venous blood
9
60
1.55
0.56
14.3
2.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
21
162
1.38
0.56
4.1
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
24
193
1.32
0.50
9.1
6.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
7
50
1.43
0.46
2.0
2.2
e9/l
4.8
3.6
—
7
40
(1761868) Lipid panel - Serum or Plasma
32
273
1.26
0.43
3.9
3.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
32
1.59
0.43
1.2
3.1
u/ml
7.8
20.6
—
5
27
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
28
235
1.27
0.43
1.9
1.7
mmol/l
1.7
1.4
0.66
19
189
(3038515) Glucose [Moles/volume] in Venous blood
0
18
0.00
0.40
0.0
3.1
—
8.1
—
0
18
(3008037) Lactate [Moles/volume] in Venous blood
0
18
0.00
0.40
0.0
3.1
—
1.5
—
0
18
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
36
1.41
0.39
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
41
1.49
0.37
1.8
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
80
764
1.27
0.33
5.8
4.5
mmol/l
1.4
1.5
0.70
73
693
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
76
727
1.21
0.27
6.3
4.5
mu/l
2.0
1.9
0.18
68
651
(3000492) Spirometry study
5
73
0.67
0.27
4.6
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
80
770
1.22
0.26
5.9
4.6
mmol/l
4.4
4.7
0.98
74
709
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
24
212
1.18
0.22
4.4
5.3
ug/l
1.6
2.0
0.56
19
188
(3002256) Pathology report gross observation
8
101
0.77
0.22
1.4
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.6
—
105.8
—
0
11
(3039443) Prostate specific Ag panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.6
—
4.1
—
0
11
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
308.0
—
0
5
(3019230) Fractional oxyhemoglobin in Venous blood
0
10
0.00
0.21
0.0
2.0
—
51.1
—
0
10
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
49
1.24
0.20
1.5
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
6
51
1.19
0.20
6.0
3.0
kpa
5.3
4.3
—
6
51
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
8
72
1.12
0.16
12.9
2.9
u/l
25.8
27.1
—
8
63
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15
167
0.88
0.12
3.1
4.7
%
19.2
22.6
—
10
86
(3011397) Hemoglobin [Presence] in Urine by Test strip
17
187
0.89
0.11
4.1
3.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
53
1.14
0.09
2.0
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
6
56
1.08
0.09
1.2
1.4
—
31.7
—
0
5
(40761535) Cells panel - Urine sediment
6
57
1.06
0.08
2.8
3.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
117
1.13
0.08
1.8
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
80
789
1.08
0.05
6.4
5.2
mmol/l
2.4
2.7
1.55
72
719
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
97
1.03
0.00
9.8
7.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(4062490)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(4268621)
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
5.1
—
0
6
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
1.9
—
0
7
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
160.4
—
0
5
(21494434) Karyotype in Bone marrow
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4010399)
5
53
0.94
0.00
2.2
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
124.0
—
0
5
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_FIT_ADJ_EXTER_PROSTHET_DEVICE – Fitting and adjustment of external prosthetic device
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).